This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 08/10/2020
Location: Teleconference
Subject: The Critical Role of Health Care Professionals During the COVID-19 Pandemic
FDA Participant/Group: DAYLE CRISTINZIO; COLIN ROM;
Non FDA Participant/Group: Several members of health care professional groups and government

Event Date: 08/12/2020
Location: Virtual
Subject: Center for Drug Evaluation and Research Scientific Rounds
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and other registered guests

Event Date: 08/13/2020
Location: Boise, ID
Subject: Roundtable on COVID-19 Efforts
FDA Participant/Group: COLIN ROM;
Non FDA Participant/Group: Idaho state, local, tribal, and public health officials

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 08/11/2020
Location: Virtual
Subject: Drug Information Association (DIA) DIRECT Webinar: Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, patients, federal government, and other stakeholders

Event Date: 08/14/2020
Location: Virtual
Subject: Technology Modernization Listening Session with Association of Clinical Research Organizations (ACRO)
FDA Participant/Group: LAURA ROE; RICHARD FORSHEE; DIANE MALONEY; PHILIP BUDASHEWITZ; RAM IYER; MIMI NGUYEN; JOSEPH FRANKLIN;
Non FDA Participant/Group: Doug Peddicord, Elyssa Clauson, Karen Noonan (Association of Clinical Research Organizations (ACRO)); Niklas Morton (PPD); Michelle Hoiseth (Parexel); Srivatsan Nagaraja (IQVIA); Jonathan Shough (Covance); Henry Levy (Veeva); Lawrence Miller (Signant Health); Jim Streeter (Oracle); Don Ragas (ERT); Ari Feldman (Medidata);

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/12/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Arizona industry executives, state government officials, and academia

Event Date: 08/13/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Danny Wegman, Dave Corsi , Gillian Kelleher (Wegmans);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event